Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

BACKGROUND: Assessment of measurable residual disease (MRD) is rapidly transforming the therapeutic and prognostic landscape of a wide range of hematological malignancies. Its prognostic value in acute lymphoblastic leukemia (ALL) has been established and MRD measured at the end of induction is incr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Hematol Oncol
Huvudupphovsmän: Pavlů, Jiří, Labopin, Myriam, Niittyvuopio, Riitta, Socié, Gerard, Yakoub-Agha, Ibrahim, Wu, Depei, Remenyi, Peter, Passweg, Jakob, Beelen, Dietrich W., Aljurf, Mahmoud, Kröger, Nicolaus, Labussière-Wallet, Hélène, Perić, Zinaida, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6813121/
https://ncbi.nlm.nih.gov/pubmed/31647022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0790-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk